Top Markets
Coin of the day
SynCore Biotechnology Co.,Ltd SynCore Biotechnology Co.,Ltd

SynCore Biotechnology Co.,Ltd

4192
Clasificación en acciones #29319
SynCore Biotechnology Co.,Ltd, a Taiwan-based enterprise, specializes in the... SynCore Biotechnology Co.,Ltd, a Taiwan-based enterprise, specializes in the development and commercialization of biotechnology services, alongside offering expertise in food advisory and medicine inspection. The company's robust pipeline includes several promising drug candidates. Among its novel chemical entities (NCEs), SB01 is an injectable anti-cancer compound currently undergoing Phase II clinical trials for head and neck cancer. Another anti-cancer NCE, SB02, is in preclinical development, targeting stomach cancer. Beyond novel compounds, SynCore also markets established pharmaceutical solutions. This includes SB03-Veregen, an ointment prescribed for external genital and perianal warts. Its portfolio further extends to SB04, a conventional medication for age-related macular degeneration, presently in Phase II clinical studies. Additionally, SynCore is advancing SB05-EndoTAG, an established drug undergoing Phase III clinical trials for the treatment of both pancreatic cancer and triple-negative breast cancer. In a related venture, the company distributes epiCam brand cameras, which are designed for recording the progression of ophthalmic diseases. SynCore maintains strategic collaborations with notable entities such as Medigene AG, MacuCLEAR Inc., Sinphar Pharmaceutical Co., Ltd., and The National Health Research Institutes. Founded in 2008, SynCore Biotechnology Co.,Ltd is headquartered in Yilan City, Taiwan, and operates as a subsidiary of Sinphar Pharmaceutical Co., Ltd.
Precio por acción
$0.62008105
Última sincronización: 2026-08-18
Capitalización bursátil
$21.81M
Cambio (1 día)
0.26%
Cambio (1 año)
-31.95%
País
TW
Comercio SynCore Biotechnology Co.,Ltd (4192)

Categoría

Historial del precio de la acción de SynCore Biotechnology Co.,Ltd (4192)
Precio más alto de cierre: $0.61 el 2026-08-01

Precio más bajo de cierre: $13.69 el 2013-08-01
Historial del precio de la acción de SynCore Biotechnology Co.,Ltd desde 2013 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -9.35%
2025 -24.35%
2024 -10.36%
2023 -62.29%
2022 -26.18%
2021 -28.63%
2020 65.85%
2019 23.95%
2018 -14.52%
2017 1.90%
2016 -35.02%
2015 -31.09%
2014 -30.70%
2013 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$552.07 41.28%
US
$168.77 504.69%
US
$1.03K 57.19%
NL
$117.42 -19.34%
AU
$753.28 8.59%
CH